Search

Search Constraints

You searched for: Author/Creator Utsumi, Takahiko

Search Results

1. Discontinuation of dasatinib in patients with chronic myeloid leukaemia who have maintained deep molecular response for longer than 1 year (DADI trial): a multicentre phase 2 trial. Issue 12 (December 2015)

2. Early disease progression in patients with localized natural killer/T‐cell lymphoma treated with concurrent chemoradiotherapy. Issue 6 (28th April 2018)

3. Final analysis of randomized phase II study optimizing melphalan, prednisolone, bortezomib in multiple myeloma (JCOG1105). Issue 9 (31st July 2022)

4. Long‐term outcomes and central nervous system relapse in extranodal natural killer/T‐cell lymphoma. Issue 4 (2nd March 2022)

5. Randomised phase II study to optimise melphalan, prednisolone, and bortezomib in untreated multiple myeloma (JCOG1105). (24th June 2020)

6. R‐High‐CHOP/CHASER/LEED with autologous stem cell transplantation in newly diagnosed mantle cell lymphoma: JCOG0406 STUDY. Issue 9 (28th July 2018)